ReviewFrontiers in microbiology2026
Host miRNA orchestration of mitophagy pathways during bacterial infection: current advances and future directions.
Review in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pathogenic bacterial infections continue to impose a substantial global health burden. MicroRNAs (miRNAs), a class of small non-coding RNAs, have emerged as critical post-transcriptional regulators of host innate immunity and inflammatory responses during bacterial pathogenesis. Accumulating evidence indicates that miRNAs dictate the outcomes of infection by orchestrating fundamental cellular processes, notably mitophagy-a selective autophagic pathway essential for mitochondrial quality control and cytosolic surveillance. While recent studies have begun to elucidate the molecular interplay between miRNA biogenesis and mitophagy regulation, the mechanistic crosstalk between miRNAs and mitophagy during bacterial infection remains fragmentary, and many reported miRNA-mitophagy regulatory relationships are derived from non-infectious disease models rather than bacterial infection settings. In this review, we synthesize current advances regarding miRNA-mediated modulation of core mitophagy machinery and associated signaling cascades in the context of bacterial infection. We further explore the pathophysiological implications of these regulatory networks and evaluate the therapeutic potential of targeting specific miRNA-mitophagy axes. This study provides mechanistic insights into how host miRNAs reprogram mitophagy to combat infection and the miRNA-mitophagy axis maybe as a promising dual-targeted therapeutic strategy for the development of host-directed therapies against bacterial diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.